AR094650A1 - CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATE - Google Patents
CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATEInfo
- Publication number
- AR094650A1 AR094650A1 ARP140100022A ARP140100022A AR094650A1 AR 094650 A1 AR094650 A1 AR 094650A1 AR P140100022 A ARP140100022 A AR P140100022A AR P140100022 A ARP140100022 A AR P140100022A AR 094650 A1 AR094650 A1 AR 094650A1
- Authority
- AR
- Argentina
- Prior art keywords
- glatiramer acetate
- product related
- pharmacological
- substance
- drug
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Proceso para caracterizar una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer que comprende los pasos de: a) obtener un lote de la una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer; b) inmunizar un mamífero con una cantidad predeterminada de una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer; c) preparar un cultivo de células del mamífero del paso b) a un tiempo predeterminado después de la inmunización; d) incubar las células del cultivo del paso c) con una cantidad predeterminada de la una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer del paso a); y e) determinar el nivel de expresión de al menos un gen descrito en la presente o determinar el nivel de actividad biológica de las células del paso c) como se describe en la presente, caracterizando de este modo la una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer del paso a).Process for characterizing a pharmacological substance or drug product related to glatiramer acetate comprising the steps of: a) obtaining a batch of the one drug substance or drug product related to glatiramer acetate; b) immunize a mammal with a predetermined amount of a drug substance or drug product related to glatiramer acetate; c) preparing a culture of mammalian cells from step b) at a predetermined time after immunization; d) incubating the culture cells of step c) with a predetermined amount of the a pharmacological substance or glaciramer acetate related product of step a); and e) determine the level of expression of at least one gene described herein or determine the level of biological activity of the cells of step c) as described herein, thereby characterizing the pharmacological substance or pharmacological product related to Glatiramer acetate from step a).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361749228P | 2013-01-04 | 2013-01-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR094650A1 true AR094650A1 (en) | 2015-08-19 |
Family
ID=56117426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100022A AR094650A1 (en) | 2013-01-04 | 2014-01-03 | CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATE |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR094650A1 (en) |
-
2014
- 2014-01-03 AR ARP140100022A patent/AR094650A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20151980A1 (en) | CHARACTERIZATION OF A GLATIRAMER ACETATE RELATED MEDICINAL PRODUCT | |
AR103161A1 (en) | ANTIMIOSTATINE ANTIBODIES AND VARIANTS FC REGIONS AS WELL AS METHODS OF USE | |
BR112020003925A2 (en) | Edible food products and bioreactor designs | |
CU20160159A7 (en) | PROCESS OF REGULATED CELL CELLULAR OF EUCARIOT CELLS AND DERIVATIVE PRODUCTS AND METHOD OF GENERATION OF VEGETABLE CELL MATERIAL IN THE FORM OF A MULTI-PAPER CELLULAR PACK, NOT WOVEN AND STRUCTURED POROUS, PRIVATE OF THE ENVIRONMENT | |
AR090017A1 (en) | FGFR1 AGONISTS AND THEIR METHODS OF USE | |
AR091098A1 (en) | ANTIBODIES AND IMMUNOCATED TO Ly6E AND METHODS OF USE | |
AR096839A1 (en) | IMPROVED PROCESS FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES | |
AR093398A1 (en) | PROPAGATION OF YEAST AT A CONTROLLED pH | |
EP4300070A3 (en) | Culture patch, culture method, method and apparatus for testing culture, and method and apparatus for testing medicine | |
MX366369B (en) | Method for a cell-based drug screening assay and the use thereof. | |
AR094389A1 (en) | USE OF iNOS INHIBITORS TO INCREASE THE VIVIC PERFORMANCE IN CROPS | |
BR112016028512A8 (en) | method of culturing a mammalian cell and method of producing a recombinant protein | |
PE20141133A1 (en) | APPARATUS AND PROCESS FOR THE PRODUCTION OF AN ENCAPSULATED CELL PRODUCT | |
BR112018012070A2 (en) | method for the production of tissues / organs using blood cells | |
MX366112B (en) | Cell culture media and methods of antibody production. | |
MX2016004616A (en) | Muscle cell patches and uses therefor. | |
IL246525B (en) | Pomegranate derived cell culture and methods for preparing and using the same | |
MX2022003399A (en) | Cellular-based method for determining the potency of defibrotide. | |
BR112018000168A2 (en) | A manufacturing method of a quality iPS cell | |
BR112015029081A2 (en) | MYCELIOPHTHORA THERMOPHILA HOST CELL EXPRESSING A RECOMBINANT BETA-XYLOSIDASE ENZYME, RECOMBINANT BETA-XYLOSIDASE ENZYME EXPRESSED THROUGH THE SAME, COMPOSITION, USE OF HOST CELL, BETA-XYLOSIDASE ENZYME OR COMPOSITION AND METHODS OF PRODUCING FERMENTED SUGARS AND PRODUCTION OF BIO PRODUCTS OF BIOMASS | |
AR104050A1 (en) | PRODUCTION PROCESS WITH CONTROLLED COPPER IONS | |
EP3067416A4 (en) | Method for introducing exogenous mitochondria into mammalian cells | |
EP3270934A4 (en) | Microcarriers, matrices and scaffolds for culturing mammalian cells and methods of manufacture | |
UY36197A (en) | BIOLOGICAL CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT DERIVED FROM GLATIRAMER ACETATE BY HUMAN AND NON-HUMAN MAMMAL CELLS | |
AR094650A1 (en) | CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |